WHO ICTRP trial
Imaging of Retinal Amyloid Plaques in Alzheimer’s disease - Middle aged Controls…
ACTRN12615000677505 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12615000677505 |
|---|---|
| Public title | Imaging of Retinal Amyloid Plaques in Alzheimer’s disease - Middle aged Controls Study |
| Scientific title | A study to evaluate retinal amyloid plaques in a middle-aged control cohort, utilizing a retinal imaging system and curcumin labeling |
| Primary sponsor | McCusker Alzheimer's Disease Foundation |
| Secondary sponsors | Neuro Vision Inc |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Alzheimer's Disease; Alzheimer's Disease;Neurological - Alzheimer's disease |
| Interventions | Suitable participants will receive a 7 day course of Curcumin and an 8 day course of over the counter Vitamin E 500IU (taken as one capsule once per day) Curcumin will be supplied in the form of Longvida (Registered Trademark) sachets… |
| Registration date | Jun 30, 2015 |
| Target size | 40 |
| Secondary IDs | NVI003.B |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: